UPDATE: Citigroup Upgrades Regeneron Pharmaceuticals
March 17, 2014 at 10:02 AM EDT
On Monday, Citigroup upgraded shares of Regeneron (NASDAQ: REGN) from Neutral to Buy and raised the price target from $342 to $390. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.